Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Hongshenghuo Biotechnology is a specialized chemical and biotechnology company based in Nanjing, China, focused on the research, development, and supply of fine chemicals, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs). The company offers a diverse catalog of over 180 products, including high-purity antibiotics such as Sitafloxacin and Moxifloxacin, as well as specialized compounds like Avibactam and Raltitrexed. Recognized as a "Golden Supplier" on major industry platforms, Nanjing Hongshenghuo serves global pharmaceutical and biotech firms with custom synthesis and high-quality chemical reagents. Its operations are centered in the Jiangning District of Nanjing, where it maintains facilities for chemical production and quality control. The company plays a key role in the life sciences supply chain by providing essential building blocks for drug discovery and manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Hongshenghuo Biotechnology.